NASDAQ:GTBP | Free Cash Flow | GT Biopharma, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2010-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$2.47M
2025-12-31-$4.02M
2025-03-31-$2.2M
2024-12-31-$2.47M
2024-03-31-$4.16M
2023-12-31-$2.05M
2023-03-31-$2.91M
2022-12-31-$4.3M
2022-03-31-$5.22M
2021-12-31-$3.71M
2021-03-31-$3.68M
2020-12-31-$1.93M
2020-03-31-$223,000.00
2019-12-31-$485,000.00$0.00-$485,000.00
2019-03-31-$961,000.00$0.00-$961,000.00
2018-12-31-$1.24M$32,000.00-$1.28M
2018-03-31-$4.23M$2,000.00-$4.23M
2017-12-31-$2.15M$4,000.00-$2.16M
2017-03-31-$650,000.00$0.00-$650,000.00
2016-12-31-$135,000.00
2016-03-31-$167,000.00
2015-12-31-$944,000.00
2015-03-31-$1.79M
2014-12-31-$1.04M
2014-03-31-$90,000.00
2013-12-31-$369,000.00
2013-03-31-$138,000.00
2012-12-31-$214,000.00
2012-03-31-$192,000.00
2011-12-31-$324,000.00
2011-03-31-$147,000.00
2010-12-31-$377,000.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$12.91M
2024-12-31-$12.9M
2023-12-31-$8.85M
2022-12-31-$15.22M
2021-12-31-$15.61M
2020-12-31-$7.26M
2019-12-31-$3.66M$0.00-$3.66M
2018-12-31-$10.68M$36,000.00-$10.71M
2017-12-31-$5.43M$4,000.00-$5.43M
2016-12-31-$1.93M$0.00-$1.93M-19.76%
2015-12-31-$4.66M$1,000.00-$4.66M
2014-12-31-$1.75M$6,000.00-$1.76M
2013-12-31-$442,000.00$0.00-$442,000.00
2012-12-31-$987,000.00$2,000.00-$989,000.00
2011-12-31-$963,000.00$0.00-$963,000.00
2010-12-31-$1.54M